AstraZeneca(AZN) - 2025 Q3 - Earnings Call Transcript
AstraZeneca (NasdaqGS:AZN) Q3 2025 Earnings Call November 06, 2025 08:00 AM ET Company ParticipantsAndy Barnett - Head of Investor RelationsRajan Sharma - Executive Director of Pharma and Biotech Equity ReserachSharon Barr - EVP of Biopharmaceuticals R&DJustin Smith - Biopharma Equity ResearchSeamus Fernandez - Senior Managing DirectorRuud Dobber - EVP of Biopharmaceuticals Business UnitAradhana Sarin - CFORichard Vosser - Managing DirectorSachin Jain - VPMarc Dunoyer - Chief Strategy OfficerMichael Leuchte ...